A NOVEL 53 KDA PROTEIN COMPLEXED WITH P210BCR-ABL IN HUMAN CHRONIC MYELOGENOUS LEUKEMIA-CELLS

被引：0
|
作者：
LI, WJ [1 ]
KLOETZER, WS [1 ]
ARLINGHAUS, RB [1 ]
机构：
[1] JOHNSON & JOHNSON BIOTECHNOL CTR INC,SAN DIEGO,CA 92121
来源：
ONCOGENE | 1988年 / 2卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：559 / 566
页数：8
相关论文
共 50 条
  • [21] Effects of transfection of p210bcr-abl and bcr-v-abl into the factor-dependent human leukemia cell line HSM-911
    Takahashi, M
    Shigeno, N
    Takahashi, H
    Suzuki, N
    Masuko, M
    Nikkuni, K
    Toba, K
    Furukawa, T
    Aoki, S
    Kishi, K
    Koike, T
    Aizawa, Y
    LEUKEMIA RESEARCH, 1997, 21 (11-12) : 1115 - 1123
  • [22] BCR/ABL mRNA and the P210BCR/ABL protein are downmodulated by interferon-α in chronic myeloid leukemia patients
    Pane, F
    Mostarda, I
    Selleri, V
    Salzano, R
    Raiola, AM
    Luciano, L
    Saglio, G
    Rotoli, B
    Salvatore, F
    BLOOD, 1999, 94 (07) : 2200 - 2207
  • [23] INDUCTION OF CHRONIC MYELOGENOUS LEUKEMIA IN MICE BY THE P210BCR/ABL GENE OF THE PHILADELPHIA-CHROMOSOME
    DALEY, GQ
    VANETTEN, RA
    BALTIMORE, D
    SCIENCE, 1990, 247 (4944) : 824 - 830
  • [24] Modulation of p210BCR-ABL activity in transduced primary human hematopoietic cells controls lineage programming
    Chalandon, Y
    Jiang, XY
    Hazlewood, G
    Loutet, S
    Conneally, E
    Eaves, A
    Eaves, C
    BLOOD, 2002, 99 (09) : 3197 - 3204
  • [25] A model of human p210bcr/ABL-mediated chronic myelogenous leukemia by transduction of primary normal human CD34+ cells with a BCR/ABL-containing retroviral vector
    Zhao, RC
    Jiang, YH
    Verfaillie, CM
    BLOOD, 2001, 97 (08) : 2406 - 2412
  • [26] Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia
    Yotnda, P
    Firat, H
    Garcia-Pons, F
    Garcia, Z
    Gourru, G
    Vernant, JP
    Lemonnier, FA
    Leblond, V
    Langlade-Demoyen, P
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (10) : 2290 - 2296
  • [27] Chronic myelogenous leukemia (CML) with the p185BCR/ABL hybrid protein.
    Ravandi-Kashani, F
    Cortes, J
    Talpaz, M
    Arlinghaus, R
    Guo, JQ
    Albitar, M
    O'Brien, S
    Kantarjian, H
    BLOOD, 1998, 92 (10) : 94A - 94A
  • [28] Bcr-Abl and inhibition of apoptosis in chronic myelogenous leukemia cells
    J. L. Fernandez-Luna
    Apoptosis, 2000, 5 : 315 - 318
  • [29] Bcr-Abl and inhibition of apoptosis in chronic myelogenous leukemia cells
    Fernandez-Luna, JL
    APOPTOSIS, 2000, 5 (04) : 315 - 318
  • [30] PHOSPHOTYROSINE PHOSPHATASE-ACTIVITY PREVENTS THE DETECTION OF P210BCR/ABL PROTEIN IN MATURE CELLS IN CHRONIC MYELOGENOUS LEUKEMIA EVEN BY AN IMMUNOBLOTTING TECHNIQUE
    SHIBATA, K
    NISHIMURA, J
    TAKAHIRA, H
    NAWATA, H
    LEUKEMIA, 1989, 3 (09) : 615 - 619
12345